EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma

Byeong Geun Song iD, Myung Ji Goh iD, Wonseok Kang iD, Dong Hyun Sinn iD, Geum-Youn Gwak iD, Moon Seok Choi iD, Joon Hyeok Lee iD, Yong-Han Paik iD

Gut and Liver · 15.07.2024 · 18 (4) · 709-718

DOI: 10.5009/gnl240085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gut and Liver, online erschienen am 27.06.2024. Verfasst von Byeong Geun Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Bevacizumab, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBevacizumabAntibodies, Monoclonal, HumanizedHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultProgression-Free SurvivalAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeRepublic of KoreaNeoplasm StagingAntineoplastic Agents, Immunological

Stichwörter der Autor:innen

Hepatocellular carcinomaImmunotherapyLiver neoplasmsSystemic therapy

Substanzen

atezolizumabBevacizumabAntibodies, Monoclonal, HumanizedAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ORCID-Profile: Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Yong-Han Paik

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare

Zitieren

APA

Song, B. G., Goh, M. J., Kang, W., Sinn, D. H., Gwak, G. Y., Choi, M. S., Lee, J. H., & Paik, Y. H. (2024). Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma. Gut and Liver, 18(4), 709-718. https://doi.org/10.5009/gnl240085

Vancouver

Song BG, Goh MJ, Kang W, Sinn DH, Gwak GY, Choi MS, et al. Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma. Gut and Liver. 2024;18(4):709-718. doi:10.5009/gnl240085

BibTeX
@article{Song2024,
  author = {Song, Byeong Geun and Goh, Myung Ji and Kang, Wonseok and Sinn, Dong Hyun and Gwak, Geum-Youn and Choi, Moon Seok and Lee, Joon Hyeok and Paik, Yong-Han},
  title = {Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma},
  journal = {Gut and Liver},
  year = {2024},
  volume = {18},
  number = {4},
  pages = {709--718},
  doi = {10.5009/gnl240085}
}
Kostenlos starten →